BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 24877083)

  • 1. Epigenetic control of autophagy by microRNAs in ovarian cancer.
    Titone R; Morani F; Follo C; Vidoni C; Mezzanzanica D; Isidoro C
    Biomed Res Int; 2014; 2014():343542. PubMed ID: 24877083
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The emerging roles of miRNA-mediated autophagy in ovarian cancer.
    Ding Y; Huang X; Ji T; Qi C; Gao X; Wei R
    Cell Death Dis; 2024 May; 15(5):314. PubMed ID: 38702325
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of Autophagy by MiRNAs and Their Emerging Roles in Tumorigenesis and Cancer Treatment.
    Chen L; Zhou Y; Sun Q; Zhou J; Pan H; Sui X
    Int Rev Cell Mol Biol; 2017; 334():1-26. PubMed ID: 28838537
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Involvement of autophagy in ovarian cancer: a working hypothesis.
    Peracchio C; Alabiso O; Valente G; Isidoro C
    J Ovarian Res; 2012 Sep; 5(1):22. PubMed ID: 22974323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum miR-1181 and miR-4314 associated with ovarian cancer: MiRNA microarray data analysis for a pilot study.
    Ruan L; Xie Y; Liu F; Chen X
    Eur J Obstet Gynecol Reprod Biol; 2018 Mar; 222():31-38. PubMed ID: 29353130
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deciphering the Long Non-Coding RNAs and MicroRNAs Coregulation Networks in Ovarian Cancer Development: An Overview.
    López-Camarillo C; Ruíz-García E; Salinas-Vera YM; Silva-Cázares MB; Hernández-de la Cruz ON; Marchat LA; Gallardo-Rincón D
    Cells; 2021 Jun; 10(6):. PubMed ID: 34204094
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deconvoluting the complexity of microRNAs in autophagy to improve potential cancer therapy.
    Yao D; Jiang Y; Gao S; Shang L; Zhao Y; Huang J; Wang J; Yang S; Chen L
    Cell Prolif; 2016 Oct; 49(5):541-53. PubMed ID: 27436709
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Repertoire of microRNAs in epithelial ovarian cancer as determined by next generation sequencing of small RNA cDNA libraries.
    Wyman SK; Parkin RK; Mitchell PS; Fritz BR; O'Briant K; Godwin AK; Urban N; Drescher CW; Knudsen BS; Tewari M
    PLoS One; 2009; 4(4):e5311. PubMed ID: 19390579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinically relevant microRNAs in ovarian cancer.
    Zhang S; Lu Z; Unruh AK; Ivan C; Baggerly KA; Calin GA; Li Z; Bast RC; Le XF
    Mol Cancer Res; 2015 Mar; 13(3):393-401. PubMed ID: 25304686
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Emerging Roles of Autophagy-Related MicroRNAs in Cancer.
    Shan C; Chen X; Cai H; Hao X; Li J; Zhang Y; Gao J; Zhou Z; Li X; Liu C; Li P; Wang K
    Int J Biol Sci; 2021; 17(1):134-150. PubMed ID: 33390839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of autophagy and its regulation by noncoding RNAs in ovarian cancer.
    Feng C; Yuan X
    Exp Biol Med (Maywood); 2023 Jun; 248(12):1001-1012. PubMed ID: 36803116
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction of autophagy with microRNAs and their potential therapeutic implications in human cancers.
    Jing Z; Han W; Sui X; Xie J; Pan H
    Cancer Lett; 2015 Jan; 356(2 Pt B):332-8. PubMed ID: 25304373
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current understanding of the functional roles of aberrantly expressed microRNAs in esophageal cancer.
    Kestens C; Siersema PD; van Baal JW
    World J Gastroenterol; 2016 Jan; 22(1):1-7. PubMed ID: 26755856
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential ceRNA networks involved in autophagy suppression of pancreatic cancer caused by chloroquine diphosphate: A study based on differentially‑expressed circRNAs, lncRNAs, miRNAs and mRNAs.
    Wei DM; Jiang MT; Lin P; Yang H; Dang YW; Yu Q; Liao DY; Luo DZ; Chen G
    Int J Oncol; 2019 Feb; 54(2):600-626. PubMed ID: 30570107
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA signatures in human ovarian cancer.
    Iorio MV; Visone R; Di Leva G; Donati V; Petrocca F; Casalini P; Taccioli C; Volinia S; Liu CG; Alder H; Calin GA; Ménard S; Croce CM
    Cancer Res; 2007 Sep; 67(18):8699-707. PubMed ID: 17875710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MARCH5 RNA promotes autophagy, migration, and invasion of ovarian cancer cells.
    Hu J; Meng Y; Zhang Z; Yan Q; Jiang X; Lv Z; Hu L
    Autophagy; 2017 Feb; 13(2):333-344. PubMed ID: 27875077
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of microRNAs in ovarian cancer initiation and progression.
    Li SD; Zhang JR; Wang YQ; Wan XP
    J Cell Mol Med; 2010 Sep; 14(9):2240-9. PubMed ID: 20345848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miR-509-3p enhances platinum drug sensitivity in ovarian cancer.
    Niu L; Ni H; Hou Y; Du Q; Li H
    Gene; 2019 Feb; 686():63-67. PubMed ID: 30408550
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LINC-PINT suppresses tumour cell proliferation, migration and invasion through targeting miR-374a-5p in ovarian cancer.
    Hao T; Huang S; Han F
    Cell Biochem Funct; 2020 Dec; 38(8):1089-1099. PubMed ID: 32638404
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A link between mir-100 and FRAP1/mTOR in clear cell ovarian cancer.
    Nagaraja AK; Creighton CJ; Yu Z; Zhu H; Gunaratne PH; Reid JG; Olokpa E; Itamochi H; Ueno NT; Hawkins SM; Anderson ML; Matzuk MM
    Mol Endocrinol; 2010 Feb; 24(2):447-63. PubMed ID: 20081105
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.